Resident Training

Support will be provided based on availability, with products and quantities selected by Galderma. Products will primarily come from the aesthetic injectable portfolio, which can be reviewed on Galderma U.S. Coporate Website, but may also include other products that could be used in an aesthetic setting. Product types and quantities are subject to change with each shipment.

Galderma does not provide medical grants to support fellow training. Please contact your local Galderma Sales Representative to request product samples for fellows.

We will not consider requests in support of the following:

• Non-ACGME-accredited residency programs, or programs outside those listed as being eligible
• Requests for product to be shipped to a fellow, resident or program coordinator.
• Residency programs outside of the U.S.

The following information is required in each application:

• Number of residents in program
• Program Director name and email address
• Product shipping address
• Detailed use of the product by program

To ensure that we can review and process your request before the end of the semester, the following submission deadlines are enforced:

Requests for the new academic year are accepted beginning on August 1st of each year. Submissions/contracts are not automatically renewed. Each program is required to submit a new request each academic year. While requests may be submitted at any time during the school year, support will not be considered for any semesters in your request for which the submission deadline has passed.

If the request is approved, a contract will be sent through DocuSign® for execution between the residency program director, injector receiving the shipment (if not the director), and Galderma. Support is contingent upon a fully executed contract and compliance with the terms and conditions of the contract.

Products are shipped directly to the licensed injector indicated on the request form. If the licensed injector differs from the Program Director, the injector accepting the shipment must also sign the agreement with Galderma and ensure proper handling of the products. Products will not be shipped to residents, fellows, or program coordinators.

Each program is responsible for ensuring the correct shipping address is included in the application and confirmed in the agreement with Galderma. Products will be shipped to this address and will not be replaced if the address is incorrect or if your facility does not receive the shipment. Deliveries are typically scheduled for Tuesday, Wednesday, or Thursday, with exact shipping dates determined by Galderma.

Galderma will not provide replacement products if they are not handled appropriately once delivered, resulting in them becoming unusable. All efforts should be made to ensure timely interception of the delivery and appropriate storage of the products, including temperature-sensitive products that are shipped cold-chain.

Please note that some products' shelf-lives may not extend the duration of the academic year. Upon receipt of the product shipment, expiration dates should be noted and a reasonable attempt to use all of the provided product should be made. Galderma will not replace products that expire prior to the end of the academic year. If product is not fully used by academic institution or expires, it should be returned to Galderma or destroyed at the institution's own expense. Granted product should only be used for the resident program training and may not be used for alternate purposes.

Requests for in-kind product must come directly from the Residency Program Director.

• The Program Director must be a licensed medical doctor (MD) or a doctor of osteopathic medicine (DO) from an ACGME-accredited dermatology, plastic surgery, otolaryngology, or ophthalmology teaching program.
• The Program Director must have a valid and current state medical license number.

Galderma does not accept Grant Requests from or for individual physicians or groups of physicians.

The following information is required to submit a request for in-kind product:

• Number of Residents in Program; and
• Quantity of In-Kind Product Requested From Galderma.

Upon approval of a request, Galderma will enter into a Letter of Agreement (LOA) with the Academic Institution as the Activity Provider. All Medical Education (ME) activities supported by Galderma must abide by the terms of Galderma's LOA; no other LOAs will be accepted. Galderma may not provide in-kind product support to the Academic Institution until a Letter of Agreement (LOA) has been fully executed. Please note that, the LOA must be executed with a reasonable amount of time left in the semester for the product training to be conducted to use the product.

The LOA requires the Academic Institution to:

• Retain control over the design and conduct of the Activity;
• Conduct the Activity independently, without any influence from Galderma;
• Ensure that the Activity is unbiased, objective, and addresses all relevant treatment options, rather than focusing on a single product;
• Provide meaningful disclosure to the audience (i.e., disclosure that is reasonably calculated to reach the relevant audience in a manner that will alert them to potential biases) at the beginning of the Activity regarding Galderma's financial support and acknowledge Galderma as a source of funding for the Activity in any written materials; and
• Make available a reasonable opportunity for discussion and a question-and-answer session at the end of the Activity.

Product is shipped directly to the Program Director at their Academic Institution only. Product will not be shipped to a resident, the Program Coordinator, any physician's private practice, or a medical facility other than the requesting Academic Institution.

The exact shipping and delivery dates will be determined by Galderma after an internal review and execution of a LOA between Galderma and the Residency Program Director on behalf of the Academic Institution as the Activity Provider. Deliveries are typically scheduled for Tuesday, Wednesday, or Thursday.

Please be aware that Dysport® has specific temperature requirements for shipping and storing. All efforts should be made to ensure that delivery is intercepted in a timely manner, as replacement product will not be provided if a delivery is missed by the Academic Institution and the product becomes no longer viable. Care should be taken to ensure that Dysport® is protected from light and that temperature control at 2°C, 8°C (36°F, 46°F) is maintained during shipping and storing.

Please note that some products' shelf-lives may not extend the duration of the semester. Upon receipt of the product(s), the Residency Program Director shall note the expiration dates and make a reasonable attempt to use all of the products provided. Galderma will not replace products that expire prior to the end of a semester given that enough time was allowed for the residency program to reasonably use the product. Once the product expires or is no longer viable, the Program Director may destroy the product at their own expense.

Activity Providers are required to notify Galderma of any of the following updates:

• Change of Scope; and
• Progress Reports, if applicable.

Any ME Activity that undergoes significant changes requires a "Change of Scope" notification to Galderma. These changes will be re-reviewed by the committee and could result in a change in the support that Galderma has committed to that ME Activity. These changes must be submitted in writing to usmedicalgrants@galderma.com. Please submit the following information:

• Reference number of original ME Activity;
• Changes from the initial grant request;
• Rationale for changes; and
• Any updated documents (e.g., activity detail, agenda, brochure, budget, etc.).

For ME Activities that include multiple components, or occur over a longer period of time, progress reports and interim update notifications of any major progress (e.g., launch of program, completion of program, etc.) should be provided to Galderma. Progress report timing will be dependent on the length of the ME Activity and may be monthly, bi-monthly, or quarterly.

Upon completion of the ME Activity, the Activity Provider must submit the following reconciliations:

• Outcomes Measurement Report;
• Budget Reconciliation; and
• Product Reconciliation.

If Galderma does not receive all reconciliations, the Activity Provider will not be allowed to request additional support from Galderma.

The Outcomes Measurement Report should detail the following:

• Program Summary
  • Type of Event/Activity
  • Participation Demographics
  • An overall summary that demonstrates the ME Activity met its stated learning objectives
• Participant Evaluation Form Summary
  • Summary of any pre-test and post-test results
• Post-activity Results Summary

The Activity Provider must be able to produce accurate documentation detailing the receipt and expenditure of Galderma's monetary grant support. This budget reconciliation must detail the following:

• Planned expenses as provided in the initial grant request application;
• Actual expenses spent during the course of the ME Activity, including how Galderma's funds were allocated;
• Unused support from Galderma; and
• Sources of income for the Activity (multi-supported activities should list all sources of income, not just the granted funds from Galderma).

If there are any unused grant funds after ME Activity completion, the Activity Provider will be required to refund an amount proportional to the amount of funding Galderma originally provided.

The Activity Provider will certify in writing that all product was used during the ME Activity, or that there is remaining unused or partially used product that needs to be returned or destroyed. The Activity Provider will send a notification e-mail following the ME Activity completion.

By submitting your request for review, you agree that the information is not confidential, nor proprietary, and may be referred to a number of different persons at Galderma to determine the level of interest in supporting your request.

Disclosure of in-kind support must be provided to the learners prior to the beginning of the educational activity, in one or more of the following: program brochures, syllabi, and other program materials, and at the time of the activity.